| Literature DB >> 29880531 |
Kei-Ichiro Inamori1, Hideki Ito1, Yumi Tamura1, Takahiro Nitta1, Xiaohua Yang1, Wataru Nihei1, Fumi Shishido1, Susumu Imazu2, Sohei Tsukita3, Tetsuya Yamada3, Hideki Katagiri3, Jin-Ichi Inokuchi4.
Abstract
GM3, a precursor for synthesis of a- and b-series gangliosides, is elevated in adipocytes of obese model animals and in sera of obese human patients with type 2 diabetes and/or dyslipidemia. GM3 synthase (GM3S)-KO C57BL/6 mice display enhanced insulin sensitivity and reduced development of high-fat diet-induced insulin resistance. However, the pathophysiological roles of GM3 and related gangliosides in the central control of feeding and metabolism remain unclear. We found that a mouse model (KKAy GM3S KO) generated by KO of the GM3S gene in the yellow obese strain, KKAy, displayed significant amelioration of obese phenotype. Whereas KKAy mice were hyperphagic and developed severe obesity, KKAy GM3S KO mice had significantly lower body weight and food intake, and greater glucose and insulin tolerance. The hypothalamic response to intraperitoneal administration of leptin was greatly reduced in KKAy mice, but was retained in KKAy GM3S KO mice. In studies of a cultured mouse hypothalamic neuronal cell line, enhanced leptin-dependent phosphorylation of ERK was observed in GM3S-deficient cells. Furthermore, KKAy GM3S KO mice did show altered coat color, suggesting that GM3S is also involved in melanocortin signaling. Our findings, taken together, indicate that GM3-related gangliosides play key roles in leptin and melanocortin signaling.Entities:
Keywords: GM3; GM3 synthase knockout; animal models; brain; diabetes; hypothalamus; leptin resistance; receptors/hormone
Mesh:
Substances:
Year: 2018 PMID: 29880531 PMCID: PMC6071761 DOI: 10.1194/jlr.M085753
Source DB: PubMed Journal: J Lipid Res ISSN: 0022-2275 Impact factor: 5.922